196 related articles for article (PubMed ID: 16302818)
1. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
Mai A; Massa S; Lavu S; Pezzi R; Simeoni S; Ragno R; Mariotti FR; Chiani F; Camilloni G; Sinclair DA
J Med Chem; 2005 Dec; 48(24):7789-95. PubMed ID: 16302818
[TBL] [Abstract][Full Text] [Related]
2. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening.
Grozinger CM; Chao ED; Blackwell HE; Moazed D; Schreiber SL
J Biol Chem; 2001 Oct; 276(42):38837-43. PubMed ID: 11483616
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Sir2: evaluation of splitomicin analogues.
Posakony J; Hirao M; Stevens S; Simon JA; Bedalov A
J Med Chem; 2004 May; 47(10):2635-44. PubMed ID: 15115404
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of Sir2 inhibitors through phenotypic assays in yeast.
Posakony J; Hirao M; Bedalov A
Comb Chem High Throughput Screen; 2004 Nov; 7(7):661-8. PubMed ID: 15578928
[TBL] [Abstract][Full Text] [Related]
5. Identification of selective inhibitors of NAD+-dependent deacetylases using phenotypic screens in yeast.
Hirao M; Posakony J; Nelson M; Hruby H; Jung M; Simon JA; Bedalov A
J Biol Chem; 2003 Dec; 278(52):52773-82. PubMed ID: 14534292
[TBL] [Abstract][Full Text] [Related]
6. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
Borra MT; Langer MR; Slama JT; Denu JM
Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
[TBL] [Abstract][Full Text] [Related]
7. The flavoring agent dihydrocoumarin reverses epigenetic silencing and inhibits sirtuin deacetylases.
Olaharski AJ; Rine J; Marshall BL; Babiarz J; Zhang L; Verdin E; Smith MT
PLoS Genet; 2005 Dec; 1(6):e77. PubMed ID: 16362078
[TBL] [Abstract][Full Text] [Related]
8. Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues.
Pasco MY; Rotili D; Altucci L; Farina F; Rouleau GA; Mai A; Néri C
J Med Chem; 2010 Feb; 53(3):1407-11. PubMed ID: 20041717
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
[TBL] [Abstract][Full Text] [Related]
10. Substrate-specific activation of sirtuins by resveratrol.
Kaeberlein M; McDonagh T; Heltweg B; Hixon J; Westman EA; Caldwell SD; Napper A; Curtis R; DiStefano PS; Fields S; Bedalov A; Kennedy BK
J Biol Chem; 2005 Apr; 280(17):17038-45. PubMed ID: 15684413
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A and Sirtinol Regulate the Expression and Nucleocytoplasmic Shuttling of Histone Deacetylases in All-Trans Retinoic Acid-Induced Differentiation of Neuroblastoma Cells.
Jang BG; Choi B; Kim S; Lee JY; Kim MJ
J Mol Neurosci; 2018 Apr; 64(4):501-511. PubMed ID: 29516351
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP.
Wang TT; Schoene NW; Kim EK; Kim YS
Mol Carcinog; 2013 Sep; 52(9):676-85. PubMed ID: 22495798
[TBL] [Abstract][Full Text] [Related]
14. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase.
Vergnes B; Vanhille L; Ouaissi A; Sereno D
Acta Trop; 2005 May; 94(2):107-15. PubMed ID: 15860278
[TBL] [Abstract][Full Text] [Related]
16. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.
Grozinger CM; Schreiber SL
Chem Biol; 2002 Jan; 9(1):3-16. PubMed ID: 11841934
[No Abstract] [Full Text] [Related]
17. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?
Jung-Hynes B; Nihal M; Zhong W; Ahmad N
J Biol Chem; 2009 Feb; 284(6):3823-32. PubMed ID: 19075016
[TBL] [Abstract][Full Text] [Related]
18. New alleles of SIR2 define cell-cycle-specific silencing functions.
Matecic M; Martins-Taylor K; Hickman M; Tanny J; Moazed D; Holmes SG
Genetics; 2006 Aug; 173(4):1939-50. PubMed ID: 16783021
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
Imai S; Armstrong CM; Kaeberlein M; Guarente L
Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin inhibition leads to autophagy and apoptosis in porcine preimplantation blastocysts.
Kim MG; Kim DH; Lee HR; Lee JS; Jin SJ; Lee HT
Biochem Biophys Res Commun; 2017 Jul; 488(4):603-608. PubMed ID: 28526407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
